Survival in female dogs with mammary neoplasia

Supervivencia en hembras caninas con neoplasia mamaria

Objective. To evaluate selected biological and histological factors associated with the survival of female dogs with mammary neoplasms. Materials and methods. An epidemiological study was performed based on the medical records of 72 female dogs diagnosed with mammary neoplasms. Associations between the characteristics of the female dogs, their reproductive status, the presence of parturition, the post-surgical survival time (m), and the final outcomes of the individual dogs were evaluated. Life tables and a Kaplan-Meier estimator were used for the statistical analysis of survival. Results. The female dogs evaluated were nulliparous (65.28%), with a mean age of 9.53±3.07 years and a weight varying between 1.5 and 49.1 kg (median 10.5 kg). The mortality incidence rate was 0.06 cases/patient/month (50 deaths/827.1 months of follow-up). Of the female dogs with mammary neoplasia, 37.50% survived, 15.28% were euthanized, and 30.56% died. The risk of death was 60.5 cases/1,000 female dogs/month, and the probability of post-surgical survival in months was 30.36%. Overall post-surgical survival was associated with the age, size, and reproductive status of the female dogs, along with size, subtype, malignancy, and TNM classification of the tumor (p<0.05). Conclusions. To ensure the survival of canine females with mammary neoplasia, early diagnosis by thorough physical examination and cytology, surgical removal when necessary, and timely consultation are imperative. Variables that are predictive of survival include the age and reproductive status of the animals and the size of the tumor.

1. Rodríguez B, Ortiz L, Garzón Alzate A, Gómez L, Vásquez Y. Valoración de la citología para el diagnóstico de tumores en caninos. Rev Colomb Ciencias Pecu. 2009; 22(1):42-53 https://revistas.udea.edu.co/index.php/rccp/article/view/324349
2. Chau V. G, Chavera C. A, Perales R, Gavidia C. C. Frecuencia de neoplasias en glándula mamaria de caninos: Estudio retrospectivo en el Periodo 1992-2006 en la ciudad de Lima, Perú. Rev Investig Vet Del Perú. 2013; 24:72–77. https://doi.org/10.15381/rivep.v24i1.1663.
3. Waters DJ, Kengeri SS, Maras AH, Suckow CL, Chiang EC. Life course analysis of the impact of mammary cancer and pyometra on age-anchored life expectancy in female Rottweilers: Implications for envisioning ovary conservation as a strategy to promote healthy longevity in pet dogs. Vet J. 2017; 224:25–37. https://doi.org/10.1016/j.tvjl.2017.05.006.
4. Brønden LB, Nielsen SS, Toft N, Kristensen AT. Data from the Danish Veterinary Cancer Registry on the occurrence and distribution of neoplasms in dogs in Denmark. Vet Rec. 2010; 166:586–590. https://doi.org/10.1136/vr.b4808.
5. Caicedo J, Iregui C, Cabarcas M, Acosta B. Estudio comparativo de la frecuencia de tumores mamarios según sexo, edad y tipo histológico en caninos y humanos en los Laboratorios de Patología Anatómica de la Universidad Nacional de Colombia, sede Bogotá. Rev Colomb Cienc Anim. 2012; 5:37–46. http://revistas.ut.edu.co/index.php/ciencianimal/article/view/124
6. Pecile A, Groppetti D, Ferrari R, Grieco V, Giudice C, Spediacci C, et al. Solitary and multiple simultaneous malignant epithelial mammary tumours in dogs: An explorative retrospective study. Res Vet Sci. 2021; 135:153–161. https://doi.org/10.1016/j.rvsc.2021.01.014.
7. Ariyarathna H, Thomson N, Aberdein D, Munday JS. Chemokine gene expression influences metastasis and survival time of female dogs with mammary carcinoma. Vet Immunol Immunopathol. 2020; 227:110075. https://doi.org/10.1016/j.vetimm.2020.110075.
8. Torres Vidales G, Eslava Mocha P. Tumores mamarios en caninos: Adenocarcinoma complejo de glándula mamaria con metástasis a ganglio linfático regional. Orinoquia. 2007; 11:99–110. https://orinoquia.unillanos.edu.co/index.php/orinoquia/article/view/175
9. Urra Palos M. Tumores de mama en perras como modelo de cáncer. Estudio de su casuística en el hospital veterinario de Zaragoza durante el curso 2011-2012. Universidad de Zaragoza: España; 2012. https://zaguan.unizar.es/record/8944/files/TAZ-TFM-2012-761.pdf
10. Andrew Novosad C. Principles of treatment for mammary gland tumors. Clin Tech Small Anim Pract. 2003; 18:107–109. https://doi.org/10.1053/svms.2003.36625.
11. Monteiro LN, dos Reis DC, Salgado BS, Cassali GD. Clinical significance and prognostic role of tumor-associated macrophages infiltration according to histologic location in canine mammary carcinomas. Res Vet Sci. 2021; 135:329-334. https://doi.org/10.1016/j.rvsc.2020.10.010.
12. Tvarijonaviciute A, Martínez-Subiela S, Cerón Madrigal J. Métodos para medir el grado de la obesidad en perros: Entre la física y la bioquímica. An Vet Murcia. 2008; 24:17–30. https://revistas.um.es/analesvet/article/view/69001
13. Elgue V, Piaggio J, Amaral C, Pessina P. Factores asociados a la presentación del tipo de cáncer en caninos atendidos en el Hospital de la Facultad de Veterinaria de Uruguay. Veterinaria. 2012; 48(187):25–30. https://www.revistasmvu.com.uy/index.php/smvu/article/view/202/132
14. Nuñez -Ochoa L, Montes de Oca-Acosta A. Frecuencia de neoplasias de glándula mamaria en perras con diagnóstico citológico. Rev Científica FCV-LUZ. 2012; 22:426–31. https://fmvz.unam.mx/fmvz/secretarias/general/articulos/52.pdf
15. Cruz Amaya J, Eraso Acosta M, Pedraza Ordoñez F. Clinical prognosis and biological factors associated with survival in canines affected by breast neoplasms. Rev CES Med Vet y Zootec. 2015; 10:170–8. https://revistas.ces.edu.co/index.php/mvz/article/view/3650
16. Perez Alenza MD, Peña L, del Castillo N, Nieto AI. Factors influencing the incidence and prognosis of canine mammary tumours. J Small Anim Pract. 2000; 41:287–291. https://doi.org/10.1111/j.1748-5827.2000.tb03203.x.
17. Pastor Sirvent N, Sirvent N. Correlación de factores pronóstico clínicos, histopatológicos e inmunohistoquímicos en tesis doctoral lesiones neoplásicas mamarias malignas en la especie canina. Universidad de Extremadura: España; 2015. http://hdl.handle.net/10662/3835
18. Egenvall A, Bonnett BN, Öhagen P, Olson P, Hedhammar Å, Euler H von. Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995 to 2002. Prev Vet Med 2005; 69:109–127. https://doi.org/10.1016/j.prevetmed.2005.01.014
19. Salas-Araujo YJ, Aburto E, Alonso R, Márquez-Alvarado AA, Corona-Monjaras H, Romero-Romero L. Association of histological features with potential risk factors and survival in canine mammary tumors. Vet México OA. 2016; 3(1):359. https://doi.org/10.21753/vmoa.3.1.359.
20. Ochoa Amaya J, LN PC, KA CA. Carcinoma complejo de glándula mamaria, acantoma queratinizante infundibular y mastocitoma tipo 3 en un canino. Rev MVZ Córdoba. 2009; 14(3):1844–1855. https://doi.org/10.21897/rmvz.345
21. Itoh T, Uchida K, Ishikawa K, Kushima K, Kushima E, Tamada H, et al. Clinicopathological survey of 101 canine mammary gland tumors: differences between small-breed dogs and others. J Vet Med Sci. 2005; 67:345–347. https://doi.org/10.1292/jvms.67.345.
22. Morris JS, Dobson JM, Bostock DE, O’Farrell E. Effect of ovariohysterectomy in bitches with mammary neoplasms. Vet Rec. 1998; 142:656–658. https://doi.org/10.1136/vr.142.24.656
23. Kristiansen VM, Peña L, Díez Córdova L, Illera JC, Skjerve E, Breen AM, et al. Effect of ovariohysterectomy at the time of tumor removal in dogs with mammary carcinomas: A randomized controlled trial. J Vet Intern Med. 2016; 30:230–241. https://doi.org/10.1111/jvim.13812
24. Borge KS, Børresen-Dale AL, Lingaas F. Identification of genetic variation in 11 candidate genes of canine mammary tumour. Vet Comp Oncol. 2011; 9:241–250. https://doi.org/10.1111/j.1476-5829.2010.00250.x.
25. Grüntzig K, Graf R, Hässig M, Welle M, Meier D, Lott G, et al. The Swiss canine cancer registry: a retrospective study on the occurrence of tumours in dogs in Switzerland from 1955 to 2008. J Comp Pathol. 2015; 152:161–171. https://doi.org/10.1016/j.jcpa.2015.02.005
26. Gavrilovic BB, Andersson K, Linde Forsberg C. Reproductive patterns in the domestic dog - A retrospective study of the Drever breed. Theriogenology. 2008; 70:783–794. https://doi.org/10.1016/j.theriogenology.2008.04.051.
27. Pedraza-Ordoñez F, Ferreira-De-La-Cuesta G, Murillo-Menjura S. Análisis retrospectivo de 124 casos de neoplasia mamaria en caninos de la ciudad de Manizales. Vet y Zootec. 2008: 2(2):21–28. http://vip.ucaldas.edu.co/vetzootec/downloads/v2n2a02.pdf
28. Rasotto R, Berlato D, Goldschmidt MH, Zappulli V. Prognostic significance of canine mammary tumor histologic subtypes: An observational cohort study of 229 cases. Vet Pathol. 2017; 54:571–578. https://doi.org/10.1177/0300985817698208
29. Yoshimura H, Nakahira R, Kishimoto TE, Michishita M, Ohkusu-Tsukada K, Takahashi K. Differences in indicators of malignancy between luminal epithelial cell type and myoepithelial cell type of simple solid carcinoma in the canine mammary gland. Vet Pathol. 2014; 51:1090–1095. https://doi.org/10.1177/0300985813516637
30. Gamazo A. Aspectos comparativos entre el cáncer mamario humano y canino con especial referencia al cáncer mamario inflamatorio: grado histológico de malignidad, mecanismos endocrinos e interleucinas. Universidad Complutense de Madrid: Epaña; 2016. https://eprints.ucm.es/id/eprint/38382/1/T37499.pdf
31. Varallo G, Gelaleti G, MaschioSignorini L, Moschetta M, Lopes J, De Nardi A, et al. Prognostic phenotypic classification for canine mammary tumors. Oncol Lett. 2019. 18(6):6545-6553. https://doi.org/10.3892/ol.2019.11052
32. Yu K-D, Jiang Y-Z, Chen S, Cao Z-G, Wu J, Shen Z-Z, et al. Effect of large tumor size on cancer-specific mortality in node-negative breast cancer. Mayo Clin Proc. 2012; 87:1171–1180. https://doi.org/10.1016/j.mayocp.2012.07.023.